NaturalShrimp Incorporated, a Biotechnology Aquaculture Company, has recently achieved a milestone in its mission to revolutionize the shrimp farming industry. The company proudly announces the successful filing of patents in key international markets, including Japan, Thailand, and Australia.

Protecting Innovative Technologies

Building upon its developments in aquaculture technology, NaturalShrimp has secured patents from the US Patent Office for its proprietary electrocoagulation technology applied in aquatic recirculating systems. These patents, represented by numbers 10,163,199 and 11,297,809, align with the emerging Environmental, Social, and Governance (ESG) principles increasingly embraced worldwide.

Recognizing the importance of safeguarding its intellectual property rights in key markets, NaturalShrimp has initiated patent filings in Japan, Thailand, Australia, and the European Patent Convention (EPC).

Expansion into Europe

Of particular significance is the company’s pursuit of patent protection within the European Patent Convention, paving the way for expansion into over forty European nations. This enables NaturalShrimp to plan its entry into European markets, including countries such as Norway, the United Kingdom, and other selected member nations.

Beyond securing existing patents, NaturalShrimp remains focused on continuous innovation. A team of researchers and experts tirelessly refines and enhances its technology, with a view to securing additional patents that address critical challenges in the aquaculture industry.